Comorbidity and gender-related differences in patients hospitalized for COPD. The ECCO study

被引:77
作者
Almagro, P. [1 ]
Lopez Garcia, F. [2 ]
Cabrera, F. J. [3 ]
Montero, L. [4 ]
Morchon, D. [5 ]
Diez, J. [6 ]
Soriano, J. B. [7 ]
机构
[1] Hosp Mutua Terrassa, Internal Med Serv, Barcelona 08221, Spain
[2] Hosp Vega Baja Orihuela, Internal Med Serv, Alicante, Spain
[3] Univ Gregorio Maranon, Internal Med Serv, Gen Hosp, Madrid, Spain
[4] Hosp Comarcal Axarquia, Internal Med Serv, Malaga, Spain
[5] Hosp Univ Rio Hortega, Internal Med Serv, Valladolid, Spain
[6] Hosp Royo Villanova, Internal Med Serv, Zaragoza, Spain
[7] Fdn Caubet CIMERA, Programa Epidemiol & Invest Clin, Baleares, Spain
关键词
COPD; Comorbidity; Gender; Hospitalization; Cardiac failure; OBSTRUCTIVE PULMONARY-DISEASE; CARDIOVASCULAR-DISEASE; MORTALITY; PREVALENCE; DIAGNOSIS; SURVIVAL; BURDEN; RISK;
D O I
10.1016/j.rmed.2009.09.019
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Rationale: Patients hospitalized for a COPD exacerbation are usually of advanced age, with functional deterioration, and suffering an increased number of associated conditions, but little is known about gender differences. Our hypothesis is that the frequency and type of comorbidities differ in mate and female COPD patients. Material and methods: A cross-sectional, multicentre study of patients hospitalized for a COPD exacerbation. All of them had COPD confirmed by baseline forced spirometry with a bronchodilator test. Comorbidity information was collected using the Charlson index, and an ad hoc questionnaire that included other common conditions not included in the Charlson index. Results: We studied 398 patients, 353 men (89%) and 45 women (11%), with a mean (S. D.) age of 73.7 (8.9) years and a percent predicted FEV1 of 43.2 (12.5). The mean score of the Charlson index was 2.7 (2.0), with no differences by gender; in contrast, the mean number of all comorbid conditions assessed was 3.7 (1.7) in men and 1.8 (1.8) in women (p < 0.05). Overall, 55% of the patients had arterial hypertension, 26% diabetes mellitus, 27% chronic heart failure, and 17% ischemic heart disease. Female COPI) patients had a lower prevalence of ischemic heart disease (p = 0.008) and alcoholism (p = 0.03), but presented more frequently with chronic heart failure (p = 0.03), osteoporosis (p = 0.007) and diabetes mellitus without complications (p = 0.02). Conclusions: Comorbidities are common in patients hospitalized for a COPD exacerbation, but their relative distribution varies by gender. The exclusive use of the Charlson index underestimates comorbidities in COPD patients. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:253 / 259
页数:7
相关论文
共 32 条
  • [1] Mortality after hospitalization for COPD
    Almagro, P
    Calbo, E
    de Echagüen, AO
    Barreiro, B
    Quintana, S
    Heredia, JL
    Garau, J
    [J]. CHEST, 2002, 121 (05) : 1441 - 1448
  • [2] ALMAGRO P, ESTUDIO ECC IN PRESS
  • [3] ANTIBIOTIC-THERAPY IN EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY-DISEASE
    ANTHONISEN, NR
    MANFREDA, J
    WARREN, CPW
    HERSHFIELD, ES
    HARDING, GKM
    NELSON, NA
    [J]. ANNALS OF INTERNAL MEDICINE, 1987, 106 (02) : 196 - 204
  • [4] Long-term mortality follow-up of the ISOLDE participants: Causes of death during 13 years after trial completion
    Bale, Geraldine
    Martinez-Camblor, Pablo
    Burge, P. Sherwood
    Soriano, Joan B.
    [J]. RESPIRATORY MEDICINE, 2008, 102 (10) : 1468 - 1472
  • [5] International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study
    Buist, A. Sonia
    McBurnie, Mary Ann
    Vollmer, William M.
    Gillespie, Suzanne
    Burney, Peter
    Mannino, David M.
    Menezes, Ana M. B.
    Sullivan, Sean D.
    Lee, Todd A.
    Weiss, Kevin B.
    Jensen, Robert L.
    Marks, Guy B.
    Gulsvik, Amund
    Nizankowska-Mogilnicka, Ewa
    [J]. LANCET, 2007, 370 (9589) : 741 - 750
  • [6] Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease
    Calverley, Peter M. A.
    Anderson, Julie A.
    Celli, Bartolome
    Ferguson, Gary T.
    Jenkins, Christine
    Jones, Paul W.
    Yates, Julie C.
    Vestbo, Jorgen
    Calverley, P. M. A.
    Anderson, J. A.
    Celli, B.
    Ferguson, G. T.
    Jenkins, C.
    Jones, P. W.
    Knobil, K.
    Yates, J. C.
    Vestbo, J.
    Cherniack, R.
    Similowski, T.
    Cleland, J.
    Whitehead, A.
    Wise, R.
    McGarvey, L.
    John, M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (08) : 775 - 789
  • [7] Characteristics of chronic obstructive pulmonary disease in Spain from a gender perspective
    Carrasco-Garrido P.
    de Miguel-Díez J.
    Rejas-Gutierrez J.
    Martín-Centeno A.
    Gobartt-Vázquez E.
    Hernandez-Barrera V.
    Gil de Miguel A.
    Jimenez-Garcia R.
    [J]. BMC Pulmonary Medicine, 9 (1)
  • [8] Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper
    Celli, BR
    MacNee, W
    Agusti, A
    Anzueto, A
    Berg, B
    Buist, AS
    Calverley, PMA
    Chavannes, N
    Dillard, T
    Fahy, B
    Fein, A
    Heffner, J
    Lareau, S
    Meek, P
    Martinez, F
    McNicholas, W
    Muris, J
    Austegard, E
    Pauwels, R
    Rennard, S
    Rossi, A
    Siafakas, N
    Tiep, B
    Vestbo, J
    Wouters, E
    ZuWallack, R
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2004, 23 (06) : 932 - 946
  • [9] Gender bias in the diagnosis of COPD
    Chapman, KR
    Tashkin, DP
    Pye, DJ
    [J]. CHEST, 2001, 119 (06) : 1691 - 1695
  • [10] VALIDATION OF A COMBINED COMORBIDITY INDEX
    CHARLSON, M
    SZATROWSKI, TP
    PETERSON, J
    GOLD, J
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 1994, 47 (11) : 1245 - 1251